4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-23-031882
President, CEO acquired 4,000 shares (grant or award)
- President, CEO acquired 6,045,100 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President, CEO | 2022-08-23 | Conversion | +6,045,100 | 6,375,414 | D | ||
| Gilad Oren President, CEO | 2023-03-09 | Grant or award | +4,000 | 322,770 | D | ||
| Derivatives | |||||||
| Gilad Oren President, CEO | 2022-08-23 | Conversion · Series A Non-Voting Convertible Preferred Stock | −604,510 | 0 | D | ||
| Gilad Oren President, CEO | 2023-03-09 | Grant or award · Stock Options (Right to Buy) | +16,000 | 16,000 | D | ||
Loading xslF345X03/tm239268d1_4.xml…